The infrastructure plays a fundamental role in the advancement of knowledge and technology in translational research and drug development.
With over 90 leading institutes, across 12 EU Member States, EATRIS provides access to the entire pipeline of academic translational infrastructure and expertise, and optimises the route from discovery to proof-of-concept in medicines development. It provides a new development pathway, open to researchers and companies in need of support for advancing biomedical innovations.
EATRIS is a non-profit European Research Infrastructure Consortium (ERIC). This specific legal form is designed to facilitate the joint establishment and operation of research infrastructures of European interest.